INIS
enzymes
100%
angiotensin
100%
nose
92%
mucosa
42%
coronaviruses
42%
patients
35%
chains
28%
fatty acids
28%
pollen
28%
cedars
28%
diseases
21%
levels
14%
tissues
14%
control
14%
inflammation
14%
receptors
14%
in vivo
7%
transmission
7%
comparative evaluations
7%
genes
7%
administration
7%
regulations
7%
messenger-rna
7%
viruses
7%
polymerase chain reaction
7%
cavities
7%
seasons
7%
Medicine and Dentistry
Angiotensin Converting Enzyme 2
100%
Nose Mucosa
42%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
COVID-19
42%
Epithelial Cell
35%
Nasal Polyp
28%
Chronic Rhinosinusitis
28%
Pollen
28%
Patient
28%
Short Chain Fatty Acid
28%
Pollen Allergy
21%
Combination Therapy
14%
Development
7%
Receptor
7%
Gene Expression
7%
Messenger RNA
7%
Serositis
7%
Upregulation
7%
Infection
7%
Real Time Polymerase Chain Reaction
7%
Nasal Cavity
7%
Endotype
7%
Nasal Tissue
7%
Subclinical Infection
7%
Virus Receptor
7%
Tissues
7%
Inpatient
7%
Regulatory Mechanism
7%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Converting Enzyme 2
100%
Chronic Rhinosinusitis
28%
Nose Polyp
28%
Japanese Cedar
28%
Short Chain Fatty Acid
28%
Pollen Allergy
21%
Messenger RNA
7%
Receptor
7%
Infection
7%
Intestine Flora
7%
Pandemic
7%
Asymptomatic Infection
7%
Virus Receptor
7%
Immunology and Microbiology
Nose Mucosa
42%
Cells
35%
Pollen
28%
Pollen Allergy
21%
Upregulation
7%
Gene Expression
7%
Real Time Polymerase Chain Reaction
7%
Nasal Tissue
7%
Tissue Level
7%
Development
7%
Intestine Flora
7%
Tissues
7%
Regulatory Mechanism
7%
Inflammation
7%
Experiment
7%
Virus
7%